4.6 Article

Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica

期刊

PLOS ONE
卷 6, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0016083

关键词

-

资金

  1. DFG [HE 2386/4-1, KO 2964/2-1, 3-1]
  2. BMBF funded competence network of Multiple Sclerosis (KKNMS)
  3. DFG funded research unit [1336]
  4. Gemeinnutzige Hertie-Stiftung
  5. Technical University Munich

向作者/读者索取更多资源

Background: Antibodies to the water channel protein aquaporin-4 (AQP4), which is expressed in astrocytic endfeet at the blood brain barrier, have been identified in the serum of Neuromyelitis optica (NMO) patients and are believed to induce damage to astrocytes. However, AQP4 specific T helper cell responses that are required for the generation of anti-AQP4 antibodies and most likely also for the formation of intraparenchymal CNS lesions have not been characterized. Methodology/Principal Findings: Using overlapping 15-meric peptides of AQP4, we identified the immunogenic T cell epitopes of AQP4 that are restricted to murine major histocompatibility complex (MHC) I-A(b). The N-terminal region of AQP4 was highly immunogenic. More precisely, the intracellular epitope AQP4(22-36) was detected as major immunogenic determinant. AQP4(82-108) (located in the second transmembrane domain), AQP4(139-153) (located in the second extracellular loop), AQP4(211-225) (located in the fifth transmembrane domain), AQP4(235-249) (located in the sixth transmembrane domain), as well as AQP4(289-306) in the intracellular C-terminal region were also immunogenic epitopes. AQP4(22-36) and AQP4(289-303) specific T cells were present in the natural T cell repertoire of wild type C57BL/6 mice and T cell lines were raised. However, active immunization with these AQP4 peptides did not induce signs of spinal cord disease. Rather, sensitization with AQP4 peptides resulted in production of IFN-gamma, but also IL-5 and IL-10 by antigen-specific T cells. Consistent with this cytokine profile, the AQP4 specific antibody response upon immunization with full length AQP4 included IgG1 and IgG2, which are associated with a mixed Th2/Th1 T cell response. Conclusions and Significance: AQP4 is able to induce an autoreactive T cell response. The identification of I-Ab restricted AQP4 specific T cell epitopes will allow us to investigate how AQP4 specific autoimmune reactions are regulated and to establish faithful mouse models of NMO that include both cellular and humoral responses against AQP4.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD)

Jonathan A. Gernert, Rebecca Wicklein, Bernhard Hemmer, Tania Kumpfel, Benjamin Knier, Joachim Havla

Summary: Peripapillary hyperreflective ovoid mass-like structures (PHOMS) has been identified as a new marker in optical coherence tomography (OCT). This study found that PHOMS occurred in 17% of AQP4+ NMOSD patients and 14% of MOGAD patients, which is comparable to the prevalence in MS patients.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis

Alexander Wuschek, Matthias Bussas, Malek El Husseini, Laura Harabacz, Viktor Pineker, Viola Pongratz, Achim Berthele, Isabelle Riederer, Claus Zimmer, Bernhard Hemmer, Jan S. Kirschke, Mark Muhlau

Summary: In patients with early multiple sclerosis (MS), abnormal tibial nerve somatosensory evoked potentials (tSSEP) were less frequent than spinal cord MRI lesions. Higher disability scores were significantly associated with abnormal tSSEP but not abnormal spinal cord MRI. Therefore, in early MS, lesions detected by MRI are the main driver of abnormal tSSEP.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Association of obesity with disease outcome in multiple sclerosis

Isabel Lutfullin, Maria Eveslage, Stefan Bittner, Gisela Antony, Martina Flaskamp, Felix Luessi, Anke Salmen, Barbara Gisevius, Luisa Klotz, Catharina Korsukewitz, Achim Berthele, Sergiu Groppa, Florian Then Bergh, Brigitte Wildemann, Antonios Bayas, Hayrettin Tumani, Sven G. Meuth, Corinna Trebst, Uwe K. Zettl, Friedemann Paul, Christoph Heesen, Tania Kuempfel, Ralf Gold, Bernhard Hemmer, Frauke Zipp, Heinz Wiendl, Jan D. Luenemann

Summary: Obesity is associated with higher disease severity and poorer outcome in newly diagnosed patients with multiple sclerosis. The presence of obesity at disease onset is linked to higher disability at baseline and at follow-up periods of 2, 4, and 6 years. Obesity management could potentially improve the clinical outcome of multiple sclerosis.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis

Josephine Wauschkuhn, Gilberto Solorza Buenrostro, Lilian Aly, Susanna Asseyer, Rebecca Wicklein, Julia Maria Hartberger, Klemens Ruprecht, Mark Muehlau, Tanja Schmitz-Huebsch, Claudia Chien, Achim Berthele, Alexander U. U. Brandt, Thomas Korn, Friedemann Paul, Bernhard Hemmer, Hanna G. G. Zimmermann, Benjamin Knier

Summary: Thinning of retinal combined ganglion cell and inner plexiform layer (GCIP) as measured by OCT is common in patients with multiple sclerosis. This study aimed to investigate whether a single retinal OCT analysis allows prediction of future disease activity after a first demyelinating event. The results showed that GCIP thickness measurement provides information for early risk stratification and progression of multiple sclerosis after the initial manifestation.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Exome-based gene panel analysis in a cohort of acute juvenile ischemic stroke patients:relevance of NOTCH3 and GLA variants

Johanna Haertl, Julia Hartberger, Silke Wunderlich, Isabell Cordts, Cemsel Bafligil, Marc Sturm, Dominik Westphal, Tobias Haack, Bernhard Hemmer, Benno David Ikenberg, Marcus Deschauer

Summary: This study found that genetic variants have a crucial impact on the occurrence of ischemic stroke in young individuals. Genetic screening can help identify genetic diseases causing stroke and provide valuable information for the medical clarification of acute stroke.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis The Antelope Phase 3 Randomized Clinical Trial

Bernhard Hemmer, Heinz Wiendl, Karsten Roth, Hendrik Wessels, Josef Hoefler, Cyrill Hornuss, Bernd Liedert, Krzysztof Selmaj

Summary: This study aimed to evaluate the matching efficacy, safety, and immunogenicity between biosim-NTZ and ref-NTZ in patients with RRMS. The results showed that biosim-NTZ matched ref-NTZ in terms of efficacy, safety, and immunogenicity. This study supports the use of biosim-NTZ as a biosimilar alternative for treating RRMS.

JAMA NEUROLOGY (2023)

Article Clinical Neurology

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Susana Otero-Romero, Christine Lebrun-Frenay, Saul Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic, Mar Tintore

Summary: This study developed a European consensus on vaccination strategies for people with multiple sclerosis (pwMS) who are candidates for disease-modifying therapies (DMTs). A multidisciplinary working group used formal consensus methodology to formulate recommendations based on the quality of evidence and risk-benefit balance. A total of 53 recommendations were agreed upon, aiming to homogenize immunization practices in pwMS.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Review Clinical Neurology

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Susana Otero-Romero, Christine Lebrun-Frenay, Saul Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic, Mar Tintore

Summary: This study aims to develop an evidence-based vaccination strategy for pwMS who are candidates for disease-modifying therapies. A multidisciplinary working group conducted a systematic literature search and formulated 53 recommendations based on the quality of evidence. The goal of this study is to homogenize immunization practices in pwMS.

MULTIPLE SCLEROSIS JOURNAL (2023)

Editorial Material Clinical Neurology

Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?

Felix Hess, Paula Uibel, Achim Berthele, Bernhard Hemmer

NERVENARZT (2023)

Article Clinical Neurology

Bony Stroke: Ischemic Stroke Caused by Mechanical Stress on Brain Supplying Arteries From Anatomical Bone or Cartilage Anomalies

Johanna Haertl, Martin Renz, Silke Wunderlich, Bernhard Hemmer, Benedikt Hofauer, Jens Gempt, Michael Kallmayer, Tobias Boeckh-Behrens, Jan S. Kirschke, Benno David Ikenberg

Summary: Bone or cartilage anomalies can cause ischemic stroke, which is referred to as bony stroke. There is no standardized diagnostic and therapeutic approach for bony strokes due to their rarity. In this study, we retrospectively analyzed the diagnostic and therapeutic workup of patients with bony strokes at our center between January 2017 and March 2022.

STROKE (2023)

Article Clinical Neurology

CNS demyelinating events in primary Sjogren's syndrome: A single-center case series on the clinical phenotype

Ali M. Afzali, Philipp Moog, Sudhakar Reddy Kalluri, Benedikt Hofauer, Andreas Knopf, Jan Stefan Kirschke, Bernhard Hemmer, Achim Berthele

Summary: The study aimed to assess the prevalence, clinical characteristics, and therapeutic outcomes of CNS demyelinating disease in patients with primary Sjogren's syndrome (pSS). Among 194 pSS patients, 22 had CNS manifestations, including 19 with demyelination. The CNS manifestations in pSS can mimic multiple sclerosis (MS), and treatment with B-cell-depleting agents may be more effective.

FRONTIERS IN NEUROLOGY (2023)

Article Clinical Neurology

Vaccination frequency in people newly diagnosed with multiple sclerosis

Sonia Darvishi, Ewan Donnachie, Christiane Gasperi, Alexander Hapfelmeier, Bernhard Hemmer

Summary: This study found that patients with MS have a lower vaccination frequency despite the risk of infection. Increasing awareness about the importance of vaccination is needed, especially in MS patients receiving immunotherapies.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Multidisciplinary Sciences

Visualizing the activation of encephalitogenic T cells in the ileal lamina propria by in vivo two- photon imaging

Isabel J. Bauer, Ping Fang, Katrin F. Lammle, Sofia Tyystjarvi, Dominik Alterauge, Dirk Baumjohann, Hongsup Yoon, Thomas Korn, Hartmut Wekerle, Naoto Kawakami

Summary: This study explores the impact of microbiota on T cell activation and their role in triggering CNS inflammation using intravital imaging. The results show that microbiota stimulation in the small intestine leads to calcium signaling in T cells, which is microbiota and MHC class II dependent. This stimulation induces the expression of Th17-axis genes in encephalitogenic T cells and facilitates their migration into the CNS.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Multidisciplinary Sciences

The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes

Dominic Bertram, Thanos Tsaktanis, Achim Berthele, Thomas Korn

Summary: Intrathecal synthesis of free light chains kappa (FLCK) is a reliable marker for differentiating inflammatory CNS pathologies, particularly autoimmune encephalitis (AIE), from non-inflammatory etiologies in subacute onset neuropsychiatric syndromes.

SCIENTIFIC REPORTS (2023)

暂无数据